• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Bipartisan senators’ bill would require Congress to approve new tariffs

by April 3, 2025
written by April 3, 2025

Two senior lawmakers have introduced a bipartisan bill that would reassert Congress’ powers over U.S. tariffs, a day after President Donald Trump announced a new wide-ranging tariff strategy during his ‘Liberation Day’ speech on Wednesday.

Sens. Chuck Grassley, R-Iowa, and Maria Cantwell, D-Wash., on Thursday introduced the Trade Review Act of 2025, which would require the president to notify Congress about any new tariffs within 48 hours of imposition. 

The bill also requires that Trump provide an explanation of the rationale along with an analysis of the tariffs’ potential impact on the U.S. economy. Congress would have to approve the new tariffs within 60 days or allow them to expire.

If enacted, the bill would shift certain trade policymaking powers from the executive branch to the Congress. 

‘For too long, Congress has delegated its clear authority to regulate interstate and foreign commerce to the executive branch,’ Grassley, a Trump ally who is skeptical of tariffs, said in a statement. 

‘Building on my previous efforts as Finance Committee Chairman, I’m joining Senator Cantwell to introduce the bipartisan Trade Review Act of 2025 to reassert Congress’ constitutional role and ensure Congress has a voice in trade policy,’ he continued.

Cantwell said in a statement that Trump’s tariffs would hurt sectors such as agriculture, manufacturing and technology and have reverberating effects on consumers.

‘Ultimately, consumers will pay the price,’ Cantwell said in a statement. ‘It’s time for Congress to take action to counter the president’s trade war.’

Grassley’s home state of Iowa heavily relies on farm crop exports, while Cantwell’s Washington state is home to many export-heavy companies such as Boeing.

Trump on Thursday compared the tariffs to a medical operation, and said the ‘patient lived, and is healing.’ ‘The prognosis is that the patient will be far stronger, bigger, better, and more resilient than ever before,’ he wrote on Truth Social.

Thursday’s bill was introduced after four Republican senators joined Democrats in approving a separate resolution on Wednesday that would repeal Trump’s emergency declaration levying tariffs on Canadian imports. Grassley was not one of the Republican defectors. The resolution is likely dead on arrival in the House.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump urged to review UN immunity, lax visa rules amid national security concerns
next post
Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

related articles

Senate stalls on shutdown vote amid warning furloughed...

October 7, 2025

Senate Republicans confirm more than 100 Trump nominees...

October 7, 2025

Trump meets former Hamas hostage Edan Alexander on...

October 7, 2025

Government limps deeper into shutdown crisis with no...

October 7, 2025

Cruz clashes with Nigeria over his claims 50,000...

October 7, 2025

House committee withdraws James Comey subpoena for Jeffrey...

October 7, 2025

Biden didn’t want intel disseminated showing Ukrainian concerns...

October 7, 2025

Oct 7 anniversary: Netanyahu finds unlikely ally amid...

October 7, 2025

Trump slams Democrats for ‘shutting down’ government, demands...

October 7, 2025

Hawley rips Jack Smith’s ‘Biden’s Stasi’ probe, calls...

October 7, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Hugo Boss sells Russian business to Stockmann, exits market over Ukraine invasion

    August 5, 2024
  • SafeMoon and Litecoin: Litecoin forms a new high at $73.53

    July 16, 2024
  • Biden says DNC anti-Israel agitators ‘have a point,’ rips Trump as ‘not worthy’ of Oval Office

    August 20, 2024
  • Infineon to slash 1,400 jobs globally and move 1,400 roles in major cost-cutting move

    August 5, 2024
  • Netanyahu publicly backs Israel-Hezbollah cease-fire plan

    November 26, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 4

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,285)
  • Investing (634)
  • Stock (936)

Latest Posts

  • Kraft Heinz to remove artificial dyes from U.S. products by end of 2027

    June 17, 2025
  • Stellar and Bitcoin Cash: Stellar in lateral consolidation

    August 13, 2024
  • Fox One streaming service to launch ahead of NFL season on Aug. 21, at $19.99 per month

    August 6, 2025

Recent Posts

  • American Airlines flight carrying US lawmakers ‘bumped’ by second plane on tarmac in DC

    April 10, 2025
  • Elon Musk warpath against Trump’s ‘big, beautiful bill’ rattles House GOP

    June 4, 2025
  • Trump announces more nominations, including Kari Lake as director of Voice of America broadcast

    December 12, 2024

Editor’s Pick

  • The dollar index is encountering resistance this morning

    August 16, 2024
  • Mike Tyson, Jake Paul fight was the most streamed sporting event ever, Netflix says

    November 20, 2024
  • Steve Bannon has two-word answer to dismiss 2028 presidential candidacy rumor

    August 7, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock